These 2 High-Yield Dividend Stocks Are on Track to Become Dividend Kings Next Year. Here's the Better Buy in May.

McDonald’s continues to look like a highly reliable dividend payer, with 2025 diluted EPS of $11.95 covering its $7.17 dividend per share and systemwide sales up 7% to $139 billion. Clorox offers a much higher 5.8% yield and a lower forward P/E of 15.5, but its turnaround remains uncertain after a cyberattack, margin pressure, and weak consumer demand. The article’s core message is that McDonald’s is the safer income stock, while Clorox is the higher-risk, higher-yield turnaround play.

Analysis

The market is effectively separating duration and quality within consumer staples: MCD is being rewarded as a bond-like equity with embedded operating leverage, while CLX is being treated as a leveraged turnaround story whose dividend is now the primary support for the stock. The second-order issue is that both names face the same macro backdrop of higher-for-longer rates and pressured household budgets, but MCD can offset that through traffic mix and pricing power, whereas CLX has to prove it can rebuild margin before the market gives it back any multiple. That means MCD’s downside is more tied to valuation compression, while CLX’s downside is tied to fundamental disappointment.

The key catalyst path is different for each. For MCD, the next re-rating comes from continued low-volatility comp growth and buybacks, which can keep per-share EPS compounding even if top-line growth moderates; for CLX, the market likely needs 2-3 consecutive quarters of visible gross margin recovery and free-cash-flow coverage before it stops pricing in a dividend reset risk. The dividend itself is not the main risk for MCD, but it is the key constraint for CLX because a payout that consumes most of cash generation reduces flexibility just when the company needs to invest to stabilize share.

Contrarian view: the consensus may be underestimating how quickly CLX can snap back if cost-out and inventory normalization finally show up in the numbers, because the stock already discounts a lot of bad news. Conversely, consensus may be overpaying for MCD’s safety premium if the market keeps rotating toward lower-duration income names with higher yields; the stock can remain high quality and still underperform if the multiple is too rich relative to its growth rate. In short, MCD is the cleaner income asset, but CLX has the more asymmetric upside if the turnaround inflects before another macro downdraft hits consumer spending.

Key Decisions for Investors

• Long MCD vs short CLX as a quality-vs-turnaround pair for 3-6 months: preferred if you want lower earnings dispersion and cleaner dividend support; risk is a sharp CLX margin surprise or a MCD multiple de-rating.
• Initiate a small tactical long CLX position only on post-earnings confirmation of gross margin and FCF improvement; target 15-20% upside if the market starts pricing a stabilized dividend, but keep a tight stop if guidance remains cash-flow constrained.
• Use MCD as a defensive income anchor, but prefer staged entries on pullbacks rather than chasing the current premium; risk/reward is better if the stock de-rates modestly while earnings continue compounding.
• For options-oriented investors, consider a CLX call spread into the next two earnings cycles to express turnaround upside with defined downside; the thesis is a re-rating on execution, not multiple expansion alone.
• Avoid treating CLX yield as a free margin of safety: if the company misses on FCF again, dividend risk can re-emerge quickly, so position sizing should reflect 1-2 quarter catalyst risk rather than a multi-year hold.